| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.591 | 4.958 | 4.735 | 4.623 | 12.411 | 3.469 | 3.428 | 2.721 | 4.076 | 3.490 |
| Total Income - EUR | 8.577 | 4.958 | 4.735 | 4.623 | 12.411 | 3.469 | 3.428 | 2.721 | 4.076 | 3.490 |
| Total Expenses - EUR | 10.148 | 5.811 | 5.476 | 5.686 | 6.486 | 3.609 | 2.874 | 7.491 | 9.531 | 9.129 |
| Gross Profit/Loss - EUR | -1.571 | -853 | -741 | -1.062 | 5.925 | -139 | 554 | -4.770 | -5.455 | -5.639 |
| Net Profit/Loss - EUR | -1.799 | -979 | -806 | -1.149 | 5.552 | -244 | 451 | -4.806 | -5.496 | -5.675 |
| Employees | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - C.c. Inject Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 9.464 | 8.403 | 8.352 | 7.210 | 12.831 | 11.681 | 11.369 | 6.944 | 3.376 | 3.318 |
| Inventories | 136 | 160 | 547 | 569 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.651 | 7.425 | 6.364 | 5.699 | 6.716 | 11.344 | 11.335 | 6.830 | 3.189 | 3.171 |
| Cash | 677 | 819 | 1.441 | 941 | 6.115 | 338 | 34 | 114 | 187 | 147 |
| Shareholders Funds | 8.982 | 7.912 | 6.972 | 5.695 | 11.171 | 10.716 | 10.929 | 6.157 | 642 | -5.036 |
| Social Capital | 46 | 45 | 45 | 44 | 43 | 42 | 41 | 41 | 41 | 41 |
| Debts | 482 | 491 | 1.381 | 1.515 | 1.660 | 966 | 440 | 786 | 2.733 | 8.354 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9531 - 9531" | |||||||||
| CAEN Financial Year |
2562
|
|||||||||
Comments - C.c. Inject Srl